Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies

Blood

Volumn 117, Issue 2, 2011, Pages 669-677

  Sachs, Ulrich J H ^a   Wasel, Wiebke ^a   Bayat, Behnaz ^a   Bohle, Rainer M ^b   Hattar, Katja ^c   Berghöfer, Heike ^a   Reil, Angelika ^d   Bux, Jürgen ^d   Bein, Gregor ^a   Santoso, Sentot ^a   Weissmann, Norbert ^c  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^d German Red Cross Blood Service West   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD DONOR; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HUMAN; HUMAN CELL; LUNG EDEMA; MALE; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; RAT; TRANSFUSION RELATED ACUTE LUNG INJURY;

EID: 78751524073     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-286146     Document Type: Article

References (49)

1. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113(15):3406-3417.
2. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774-1789.
3. Wallis JP, Sachs UJ. Transfusion-related acute lung injury. In: Simon TL, Snyder EL, Solheim BG, Stowell CP, Strauss RG, Petrides M, eds. Rossi's Principles of Transfusion Medicine. Vol 4. Bethesda, MD: American Association of Blood Banks; 2009:870-884.
4. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol. 2007;136(6):788-799. (Pubitemid 46348408)
5. Eder AF, Herron R, Strupp A, et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 2007;47(4):599-607.
6. Middelburg RA, van Stein D, Briët E, van der Bom JG. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion. 2008;48(10):2167-2176.
7. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009;49(9):1825-1835.
8. Vassallo RR, Hsu S, Einarson M, Barone J, Brodsky J, Moroff G. A comparisuon of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy. Transfusion. 2010;50(8):1766-1777).
9. Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex-vivo lung model. Blood. 1990;76(7):1438-1444. (Pubitemid 20342763)
10. Sachs UJ, Hattar K, Weissmann N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex-vivo rat lung model. Blood. 2006;107(3):1217-1219. (Pubitemid 43156327)
11. Silliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood. 2007;109(4):1752-1755.
12. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest. 2006;116(6):1615-1623.
13. Kelher MR, Masuno T, Moore EE, et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood. 2009;113(9):2079-2087.
14. Fung YL, Silliman CC. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev. 2009;23(4):266-283.
15. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41(10):1244-1248. (Pubitemid 33000960)
16. Varela M, Mas A, Nogués N, Escorsell A, Mazzara R, Lozano M. TRALI associated with HLA class II antibodies [letter]. Transfusion. 2002;42(8):1102.
17. Win N, Brown C, Navarrete C. TRALI associated with HLA class II antibodies. Transfusion. 2003;43(4):545-456.
18. Lydaki E, Bolonaki E, Nikoloudi E, Chalkiadakis E, Iniotaki-Theodoraki A. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report. Transfus Apher Sci. 2005;33(2):107-111.
19. Porretti L, Coluccio E, Prati D, et al. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report. Eur J Haematol. 2004;73(4):295-299.
20. Flesch BK, Neppert J. Transfusion-related acute lung injury caused by human leucocyte antigen class II antibody. Br J Haematol. 2002;116(3):673-676. (Pubitemid 34178673)
21. Wallis JP, Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion. 2003;43(8):1053-1059.
22. Win N, Massey E, Lucas G, et al. Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome. Hematology. 2007;12(5):461-469.
23. Reil A, Keller-Stanislawski B, Günay S, Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2008;95(4):313-317.
24. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2009;49(3):440-452.
25. Keller-Stanislawski B, Reil A, Günay S, Funk MB. Frequency and severity of transfusion-related acute lung injury-German haemovigilance data (2006-2007). Vox Sang. 2010;98(1):70-77.
26. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003;43(2):177-184.
27. Nishimura M, Hashimoto S, Takanashi M, Okazaki H, Satake M, Nakajima K. Role of antihuman leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med. 2007;17(2):129-134. (Pubitemid 46558245)
28. BD Biosciences. 2008. In vitro study of cytokine-mediated activation of endothelial cell permeability using BD Falcon Cell Culture Inserts. Technical Bulletin #413. http://www.bdbiosciences.com/. Accessed April 14, 2010.
29. Ermert L, Ermert M, Althoff A, Merkle M, Grimminger F, Seeger W. Vasoregulatory prostanoid generation proceeds via cyclooxygenase-2 in noninflamed rat lungs. J Pharmacol Exp Ther. 1998;286(3):1309-1314. (Pubitemid 29135544)
30. Seeger W, Walmrath D, Menger M, Neuhof H. Increased lung vascular permeability after arachidonic acid and hydrostatic challenge. J Appl Physiol. 1986;61(5):1781-1789. (Pubitemid 17196235)
31. Shasby DM, Lind SE, Shasby SS, Goldsmith JC, Hunninghake GW. Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis. Blood. 1985;65(3):605-614.
32. Sachs UJ, Chavakis T, Fung L, et al. Human alloantibody anti-Mart interferes with Mac-1-dependent leukocyte adhesion. Blood. 2004;104(3):727-734.
33. Greinacher A, Wesche J, Hammer E, et al. Characterization of the human neutrophil alloantigen-3a. Nat Med. 2010;16(1):45-48.
34. Holman RG, Maier RV. Oxidant-induced endothelial leak correlates with decreased cellular energy levels. Am Rev Respir Dis. 1990;141(1):134-140.
35. Johnson A, Phillips P, Hocking D, Tsan MF, Ferro T. Protein kinase inhibitor prevents pulmonary edema in response to H2O2. Am J Physiol. 1989;256(4 Pt 2):H1012-H1022.
36. Barnard ML, Matalon S. Mechanisms of extracellular reactive oxygen species injury to the pulmonary microvasculature. J Appl Physiol. 1992;72(5):1724-1729.
37. Seeger W, Hansen T, Rössig R, et al. Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability-effect of adenylate cyclase stimulation and phosphodiesterase inhibition. Microvasc Res. 1995;50(1):1-17.
38. Metzner B, Barbisch M, Parlow F, Kownatzki E, Schraufstatter I, Norgauer J. Interleukin-8 and GRO alpha prime human neutrophils for superoxide anion production and induce up-regulation of N-formyl peptide receptors. J Invest Dermatol. 1995;104(5):789-791.
39. Wyman TH, Bjornsen AJ, Elzi DJ, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 2002;283(6):C1592-C1603.
40. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84(4):1045-1049. (Pubitemid 19247571)
41. Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol. 1998;30(2):173-178.
42. Koike J, Nagata K, Kudo S, Tsuji T, Irimura T. Density-dependent induction of TNF-alpha release from human monocytes by immobilized P-selectin. FEBS Lett. 2000;477(1-2):84-88. (Pubitemid 30438862)
43. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest. 2009;119(11):3450-3461.
44. Mudzinski SP, Christian TP, Guo TL, Cirenza E, Hazlett KR, Gosselin EJ. Expression of HLA-DR (major histocompatibility complex class II) on neutrophils from patients treated with granulocyte-macrophage colony-stimulating factor for mobilization of stem cells. Blood. 1995;86(6):2452-2453.
45. Reinisch W, Lichtenberger C, Steger G, et al. Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo. Clin Exp Immunol. 2003;133(3):476-484.
46. Hänsch GM, Radsak M, Wagner C, et al. Expression of major histocompatibility class II antigens on polymorphonuclear neutrophils in patients with Wegener's granulomatosis. Kidney Int. 1999;55(5):1811-1818.
47. Pober JS, Collins T, Gimbrone MA Jr, Libby P, Reiss CS. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation. 1986;41(2):141-146.
48. Kao GS, Wood IG, Dorfman DM, Milford EL, Benjamin RJ. Investigations into the role of anti-HLA class II antibodies in TRALI. Transfusion. 2003;43(2):185-191.
49. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8(8):504-512.